Sangamo Therapeutics
(NASDAQ:SGMO)
$0.5196
-0.0203[-3.76%]
At close: May 8
$0.5196
0[0.00%]
After Hours: 7:57PM EDT
Q1 2024 earnings tomorrow on Thu May 9th after the market close
Conference call scheduled tomorrow at 16:30 PM Click to view the webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Sangamo Therapeutics Stock (NASDAQ:SGMO), Quotes and News Summary

Sangamo Therapeutics Stock (NASDAQ: SGMO) stock price, news, charts, stock research, profile.

Open$0.530
Close$0.502
Volume / Avg.1.573M / 2.330M
Day Range0.495 - 0.544
52 Wk Range0.291 - 1.670
Market Cap$107.815M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
43
Short Interest
6.42%
Days to Cover7.56

Recent News

Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform
Unlock potential with Voyager Therapeutics as HC Wainwright initiates coverage highlights its TRACER capsid platform, promising CNS-targeted gene therapies and strategic partnerships driving long-term value.
Vandana Singh
Why Palantir Technologies Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Shares of Palantir Technologies Inc. (NYSE: PLTR) rose sharply during today’s pre-market trading after the company reported better-than-expected fourth-quarter sales results and issued guidance.
Avi Kapoor
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Jan
2
Feb
2
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.6
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
SGMO
MOLN

FAQ

Q

How do I buy Sangamo Therapeutics (SGMO) stock?

A

You can purchase shares of Sangamo Therapeutics (NASDAQ: SGMO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Sangamo Therapeutics's (SGMO) competitors?

A

Other companies in Sangamo Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Anixa Biosciences (NASDAQ:ANIX), Cellectar Biosciences (NASDAQ:CLRB), Curis (NASDAQ:CRIS) and Armata Pharmaceuticals (AMEX:ARMP).

Q

What is the target price for Sangamo Therapeutics (SGMO) stock?

A

The latest price target for Sangamo Therapeutics (NASDAQ: SGMO) was reported by HC Wainwright & Co. on Tuesday, March 19, 2024. The analyst firm set a price target for 5.00 expecting SGMO to rise to within 12 months (a possible 862.28% upside). 17 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Sangamo Therapeutics (SGMO)?

A

The stock price for Sangamo Therapeutics (NASDAQ: SGMO) is $0.5196 last updated May 8, 2024 at 7:57 PM EDT.

Q

Does Sangamo Therapeutics (SGMO) pay a dividend?

A

There are no upcoming dividends for Sangamo Therapeutics.

Q

When is Sangamo Therapeutics (NASDAQ:SGMO) reporting earnings?

A

Sangamo Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.

Q

Is Sangamo Therapeutics (SGMO) going to split?

A

There is no upcoming split for Sangamo Therapeutics.

Q

What sector and industry does Sangamo Therapeutics (SGMO) operate in?

A

Sangamo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch